TOKYO–( ORGANIZATION CORD)– RevolKa Ltd. (RevolKa), a venture-backed biotech firm supplying an innovative AI-driven healthy protein design modern technology system, called aiProtein ® introduced the closing of a 100 million JPY (US$ 0.7 M) funding, and has actually finished a total amount of 250 million JPY (US$ 1.7 M) in the Collection An expansion financing. We likewise introduced the launch of a medicine exploration program for unusual conditions on July 30th, 2024. (https://www.revolka.com/news/english/collab-en/a65) A few of our medication candi
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/revolka-ltd-announces-the-closing-of-a-250-million-jpy-us1-7-million-series-a-extension-funding-to-accelerate-drug-discovery-programs/
